Q2 2026 Tatva Chintan Pharma Chem Ltd Earnings Call Transcript

Oct 31, 2025 / 11:30 AM GMT

Release Date Price: ₹1413.95 (+4.24%)

Transcript

Key Points

Positve

Tatva Chintan Pharma Chem Ltd (BOM:543321) reported a 48% year-on-year growth in operating revenue, reaching INR1,235 million.
EBITDA saw a significant increase of 298% year-on-year, supported by improved product mix and better operating leverage.
The Structure Directing Agents segment reported a 51% growth quarter-on-quarter and a 119% increase year-on-year.
The company is witnessing positive demand trends in the SDA segment, driven by developments in the automotive sector and upcoming emission standards.
Tatva Chintan Pharma Chem Ltd (BOM:543321) is fully backward integrated in the electrolyte salts segment, providing a competitive advantage.

Negative

Electrolyte salts revenue declined by 5% year-on-year, despite a 47% sequential growth.
Pharma Agro and Specialty chemicals segment experienced a 31% sequential decline in revenue.
Geopolitical uncertainties and reciprocal tariff measures in the United States pose potential risks.
The company is facing challenges in the agro industry, with some products under volume constraints.
The semiconductor chemicals segment's full-scale commercialization is expected to be gradual, with significant progress not anticipated until 2028.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TATV.NS - Tatva Chintan Pharma Chem Ltd
Q2 2026 Tatva Chintan Pharma Chem Ltd Earnings Call
Oct 31, 2025 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the merchant and Pharmacam Limited Q2 F 526 earnings conference call hosted by ICICI Securities Limited.

As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference, please signal an operator by pressing, then 0 on a touchstone telephone. Please note this conference is being recorded. I now hand the conference over to Mr. Sanjay Jain.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.